Literature DB >> 19574069

Pelvic venous incompetence: reflux patterns and treatment results.

G Asciutto1, K C Asciutto, A Mumme, B Geier.   

Abstract

OBJECTIVE: To assess reflux patterns and the results of endovascular obliteration of ovarian veins in patients with symptomatic pelvic venous incompetence (PVI).
METHODS: A total of 71 female patients (mean age 49 years) with signs of PVI on selective phlebography of the pelvic veins were included in the study. In 53 cases (75%), recurrent varicose veins following previous surgery and stripping of the great saphenous vein were present and 51 patients (72%) were multiparous (> or = 2 children). Symptoms were scored on a visual analogue scale (VAS) assessing pelvic and lower limb pain. After duplex ultrasonography of the lower limb veins, in cases of suspected PVI, the presence of any reflux in the ovarian and pelvic veins was demonstrated by phlebography. In selected cases, endovascular treatment with embolisation was used. Follow-up assessment of symptoms was carried out at 1, 2 and 3 years.
RESULTS: The left ovarian vein (OV) and the right internal iliac vein (IIV) were most frequently affected by reflux (n=41, 58% each). In about half the number of patients, reflux was demonstrated in more than one of the main pelvic veins (n=38, 54%). An extension of reflux into varicose veins of the groin or lower limb was demonstrated in 44 patients (62%); 35 patients (49%) received treatment for their PVI by coil embolisation. Fifty-five patients (77%) completed follow-up. Patients with isolated ovarian vein incompetence, who were treated by embolisation, experienced a significant improvement of symptoms (mean symptom score 5.2 standard deviation (SD) 3.5 before and 1.2 SD 0.9 after embolisation treatment; p<0.0001), while patients with untreated incompetence did not show improvement in symptoms (mean score 4.5 SD 1.6 before and 5.1 SD 1.5 after conservative treatment; non-significant (N.S.)). Improved symptoms were detected in patients with isolated IIV incompetence, who underwent embolisation treatment (mean symptom score 5.1 SD 2.5 before and 2.1 SD 1.6 after treatment; N.S.) although this did not reach statistical significance. Conservative treatment of patients with isolated IIV incompetence resulted in no relevant changes (mean score 4.2 SD 2.0 before and 4.5 SD 2.1 after treatment; N.S.). Worsening of symptoms was found in patients with combined reflux who underwent conservative treatment (mean score 5.3 SD 2.0 before and 6.5 SD 2.5 after treatment, N.S.). In case of combined OV and IIV reflux, isolated interventional treatment of incompetent ovarian veins did not improve symptoms at each interval of the follow-up (mean score 5.2 SD 2.1 before and 5.1 SD 2.6 after treatment, N.S.), while coiling of all reflux pathways resulted in symptom reduction; but this did not reach statistical significance due to the small numbers of patients (mean score 5.6 SD 2.2 before and 3.2 SD 2.1 after treatment, N.S.).
CONCLUSIONS: Combined reflux in more than one pelvic vein is common. In these cases, isolated treatment of ovarian veins or conservative treatment is associated with a poor midterm clinical outcome. A clinical improvement was achieved only in patients with isolated ovarian vein incompetence.

Entities:  

Mesh:

Year:  2009        PMID: 19574069     DOI: 10.1016/j.ejvs.2009.05.023

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  14 in total

Review 1.  Pelvic Congestion Syndrome: Systematic Review of Treatment Success.

Authors:  Candace L Brown; Magda Rizer; Ryan Alexander; Emerson E Sharpe; Paul J Rochon
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

2.  The effect of pregnancy on venous valve repair to the sapheno-femoral junction for varicose veins.

Authors:  Martijn L Dijkstra; Nyan Y Khin; John C Coroneos; Stuart Hazelton; Rodney J Lane
Journal:  Obstet Med       Date:  2014-03-11

3.  Radiologic findings of pelvic venous congestion in an adolescent girl with angiographic confirmation and interventional treatment.

Authors:  Carolyn Wassong; Bina Shah; Masahide Kanayama; Haraldur Bjarnason; Sarah S Milla
Journal:  Pediatr Radiol       Date:  2011-09-13

4.  Time-resolved MR angiography for detecting and grading ovarian venous reflux: comparison with conventional venography.

Authors:  D M Yang; H C Kim; D H Nam; G H Jahng; C Y Huh; J W Lim
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

Review 5.  Choosing the Most Appropriate Treatment Option for Pelvic Venous Disease: Stenting versus Embolization.

Authors:  Mari E Tanaka; Oleksandra Kutsenko; Gloria Salazar
Journal:  Semin Intervent Radiol       Date:  2021-06-03       Impact factor: 1.780

Review 6.  Female Pelvic Vein Embolization: Indications, Techniques, and Outcomes.

Authors:  Anthony James Lopez
Journal:  Cardiovasc Intervent Radiol       Date:  2015-03-25       Impact factor: 2.740

7.  Duplex ultrasound in the assessment of lower extremity venous insufficiency.

Authors:  Martin Necas
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

8.  Evaluation of embolization for periuterine varices involving chronic pelvic pain secondary to pelvic congestion syndrome.

Authors:  Flavio Meirelles Siqueira; Lucas Moretti Monsignore; Julio Cesar Rosa-E-Silva; Omero Benedicto Poli-Neto; Luis Henrique de Castro-Afonso; Guilherme Seizem Nakiri; Valdair Francisco Muglia; Daniel Giansante Abud
Journal:  Clinics (Sao Paulo)       Date:  2016-12-01       Impact factor: 2.365

Review 9.  Pelvic vein incompetence: clinical perspectives.

Authors:  David M Riding; Vivak Hansrani; Charles McCollum
Journal:  Vasc Health Risk Manag       Date:  2017-11-27

10.  The effect of the ovarian varicose vein on the DNA methylation in the rat's oocyte.

Authors:  Amirhossein Mohammadi; Bagher Minaei Zangi; Mahshid Delfan Azari; Rafieh Alizadeh; Mohammad Salehi; Erfan Daneshi; Mohammad Jafar Rezaei; Mehdi Abbasi
Journal:  Iran J Basic Med Sci       Date:  2017-10       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.